As the first sublingual preparation of fentanyl, Abstral was a landmark for ProStrakan and a milestone in the treatment of breakthrough cancer pain.
Life played a major part in the success of the brand, from pre-launch planning to market leadership. The core campaign we developed is now used throughout Europe.
